SCHEMBL6492047

SCHEMBL6492047

Nc1ccc(-c2nc3c(Cl)cc(N)cc3[nH]2)cc1

nearest known ligand 1.00 ✓ in ChEMBL — recovers established targets

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ MEN1 O00255 10/20 1.00
▸ KMT2A Q03164 10/20 1.00
▸ ALDH1A1 P00352 10/20 1.00
▸ MAPT P10636 9/20 1.00
▸ HPGD P15428 9/20 1.00
▸ KDM4E B2RXH2 8/20 1.00
▸ GAA P10253 7/20 1.00
▸ HSD17B10 Q99714 5/20 1.00
▸ GFER P55789 4/20 1.00
▸ BLM P54132 3/20 1.00
▸ LMNA P02545 3/20 1.00
▸ NPSR1 Q6W5P4 2/20 1.00
▸ MITF O75030 1/20 1.00
▸ SMN1; SMN2 Q16637 9/20 0.59
▸ NPC1 O15118 9/20 0.59
▸ RAB9A P51151 8/20 0.59
▸ TP53 P04637 6/20 0.59
▸ GLA P06280 4/20 0.59
▸ CACNA1B Q00975 3/20 0.59
▸ APBA1 Q02410 3/20 0.59

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6482684 0.81 MEN1 (0.68) MEN1KMT2AALDH1A1MAPTHPGD
SCHEMBL19994538 0.77 GAA (0.62) MEN1KMT2AALDH1A1MAPTHPGD
SCHEMBL6324494 0.75 RHEB (0.69) MEN1KMT2AALDH1A1MAPTHPGD
SCHEMBL6492052 0.74 ALDH1A1 (0.59) MEN1KMT2AALDH1A1MAPTHPGD
SCHEMBL6494910 0.74 MEN1 (1.00) MEN1KMT2AALDH1A1MAPTHPGD
SCHEMBL6482060 0.74 RPS6KA3 (0.64) MEN1KMT2AALDH1A1MAPTHPGD
SCHEMBL27236913 0.73 GAA (0.57) MEN1KMT2AALDH1A1MAPTHPGD
SCHEMBL11440973 0.73 MEN1 (0.65) MEN1KMT2AALDH1A1MAPTHPGD
SCHEMBL31474741 0.73 RPS6KA3 (0.64) MEN1KMT2AALDH1A1MAPTHPGD
SCHEMBL11443268 0.73 MEN1 (0.65) MEN1KMT2AALDH1A1MAPTHPGD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20050260126-A1 Diagnostic probes and remedies for diseases with accumulation of prion protein, and stains for prion protein BF RESEARCH INSTITUTE (JP) 2005-11-24 — — US disclosed
US-4225492-A Water-soluble disazo dyestuffs, prepared from unsymmetrical heterocyclic diamines CASSELLA AKTIENGESELLSCHAFT (DE) 1980-09-30 — — US disclosed
US-4144231-A Soluble trisazo dyestuffs containing a 2-phenyl-benzimidazolyl, -benzoxazolyl or -benzthiazolyl middle component CASSELLA AKTIENGESELLSCHAFT (DE) 1979-03-13 — — US disclosed
US-4144230-A Soluble trisazo dyestuffs containing a 2-phenyl-benzimidazolyl, -benzoxazolyl or -benzthiazolyl middle component CASSELLA AKTIENGESELLSCHAFT (DE) 1979-03-13 — — US disclosed
US-4143033-A WATER-SOLUBLE DISAZO DYESTUFFS CONTAINING A 2-PHENYL-BENZIMIDAZOLYL,-BENZOXAZOLYL OR-BENZTHIAZOLYL MIDDLE COMPONENT CASSELLA AKTIENGESELLSCHAFT (DE) 1979-03-06 — — US disclosed
US-4137228-A HIGH TINCTORIAL STRENGTH, COLORFASTNESS CASSELLA AKTIENGESELLSCHAFT (DE) 1979-01-30 — — US disclosed
US-4033945-A Water-soluble trisazo 8-amino-naphthol-1 dyes CASSELLA FARBWERKE MAINKUR AKTIENGESELLSCHAFT (DT) 1977-07-05 — — US disclosed
US-4024125-A Dis-azo pigments deriving from bis-diazotized diamino-2-phenyl-benzazolones HOECHST AKTIENGESELLSCHAFT (DT) 1977-05-17 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050260126-A1 Diagnostic probes and remedies for diseases with accumulation of prion protein, and stains for prion protein PRNP, PRPH, PCNP MEN1 3565/4885KMT2A 3291/4885ALDH1A1 1577/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback